Cra­dle Bio rais­es $73M Se­ries B to sell phar­ma its pro­tein-mak­ing AI soft­ware

Eu­ro­pean start­up Cra­dle Bio raised a $73 mil­lion Se­ries B round, fu­el­ing its plans to sell its AI-based pro­tein-mak­ing soft­ware to more drug­mak­ers.

Cra­dle …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER